Comparable efficacy of venetoclax 50mg with posaconazole versus venetoclax 400mg in newly diagnosed AML patients: A prospective study of pharmacokinetics, toxicity, and clinical outcomes.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Gaurav Prakash, Rudra Narayan Swain, Anu Kumari, Smita Pattanaik, Charanpreet Singh, Arihant Jain, Alka Khadwal, Pankaj Malhotra
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410809322